Dexmedetomidine Hydrochloride Nasal Spray(Shanghai Hengrui Pharma)

盐酸右美托咪定鼻喷雾剂(上海恒瑞医药)

Report date: 2026/02/12 20:00:14

Base Information

Drug NameDexmedetomidine Hydrochloride Nasal Spray(Shanghai Hengrui Pharma)
Drug Alias NameDEX-TD盐酸右美托咪啶DEX-SL右美托咪定Dexmedetomidinum +[8
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 agonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsSedationBreast Neoplasms
Global Approved IndicationsSedation
Approved Indications in ChinaSedation
Original Approved Country/TerritoryMainland China
Original Approved Date2023/03/15
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Active IndicationsSedationBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A